SC 13D

Company

Altimmune, Inc.

Filed

August 14, 2007

Accession Number

0001116502-07-001541

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →